Electronically facilitated transdermal delivery of human parathyroid hormone (1-34)

被引:36
|
作者
Medi, BA [1 ]
Singh, J [1 ]
机构
[1] N Dakota State Univ, Coll Pharm, Dept Pharmaceut Sci, Fargo, ND 58102 USA
关键词
transdermal drug delivery; electroporation; iontophoresis; hPTH (1-34); porcine skin;
D O I
10.1016/S0378-5173(03)00337-5
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Electronically facilitated transdermal delivery of human parathyroid hormone (1-34), hPTH (1-34), was investigated in vitro, using dermatomed porcine skin. The effect of iontophoretic current density,electroporative pulse voltages and also electroporation followed by iontophoresis was investigated on the in vitro percutaneous absorption of hPTH (1-34). Iontophoresis at 0.5 mA/cm(2) Current density significantly enhanced (P < 0.05) the flux of hPTH (1-34) in comparison to passive flux. Electroporation pulses of 100, 200 and 300 V significantly increased (P < 0.05) the flux of hPTH (1-34) in comparison with the passive as well as iontophoretic flux at 0.5 mA/cm(2). The electroporative flux of hPTH (1-34) was found to vary linearly (R-2 = 0.97) with the pulse amplitude. The principal barrier of the skin, stratum corneum, was found perturbed following the pulses as evident by light microscopy studies. The application of electroporation pulses followed by iontophoresis further increased the flux by several fold. The flux of hPTH (1-34) with the electroporation Pulses Of 100 and 300V followed by iontophoresis at 0.2 mA/cm(2) was 10- and 5-fold higher, respectively, in comparison to the flux with corresponding pulses alone. This shows the synergistic effect of iontophoresis in combination with electroporation on skin permeability of hPTH (1-34). The results indicate the possibility of designing controlled transdermal delivery systems for hPTH (1-34) using electroporation followed by iontophoresis. (C) 2003 Elsevier B.V. All rights reserved.
引用
收藏
页码:25 / 33
页数:9
相关论文
共 50 条
  • [31] PROPERTIES OF ANTISERA AGAINST SYNTHETIC 1-34 HUMAN PARATHYROID-HORMONE
    VISSER, TJ
    BUURMAN, CJ
    HACKENG, WHL
    BIRKENHAGER, JC
    JOURNAL OF ENDOCRINOLOGY, 1975, 67 (01) : 141 - 142
  • [32] THE STRUCTURE OF HUMAN PARATHYROID-HORMONE (1-34) AS INDUCED BY SOLVENTS AND MICELLES
    STRICKLAND, LA
    BOZZATO, RP
    KRONIS, KA
    JOURNAL OF CELLULAR BIOCHEMISTRY, 1993, : 309 - 309
  • [33] Parathyroid hormone(1-34) and parathyroid hormone-related protein(1-34) stimulate calcium release from human syncytiotrophoblast basal membranes via a common receptor
    Farrugia, W
    de Gooyer, T
    Rice, GE
    Moseley, JM
    Wlodek, ME
    JOURNAL OF ENDOCRINOLOGY, 2000, 166 (03) : 689 - 695
  • [34] Development of a highly sensitive and specific two-site enzyme immunoassay for parathyroid hormone (1-34): Application to pharmacokinetic study on intranasal parathyroid hormone (1-34) in human
    Kohno, T
    Murasugi, N
    Sakurai, H
    Watabe, K
    Nakamuta, H
    Koida, M
    Sugie, Y
    Nomura, M
    Yanagawa, A
    JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1998, 12 (05) : 268 - 275
  • [35] A Novel Parathyroid Hormone 1-34 Plasmid Gene Delivery System for Enhanced Bone Repair
    Matheson, Austyn
    Sadowska, Joanna
    Sperger, Simon
    Power, Rachael
    Grillari, Johannes
    O'Brien, Fergal
    TISSUE ENGINEERING PART A, 2023, 29 (13-14)
  • [36] In vivo and in vitro comparison of LY333334, biosynthetic human parathyroid hormone (hPTH) (1-34), with synthetic hPTH(1-34).
    Black, EC
    Frolik, CA
    Hock, JM
    Cain, RL
    Chandrasekhar, S
    Harvey, AK
    JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 : F370 - F370
  • [37] Parathyroid hormone 1-34 and skeletal anabolic action THE USE OF PARATHYROID HORMONE IN BONE FORMATION
    Osagie-Clouard, L.
    Sanghani, A.
    Coathup, M.
    Briggs, T.
    Bostrom, M.
    Blunn, G.
    BONE & JOINT RESEARCH, 2017, 6 (01): : 14 - 21
  • [38] Restoring effect of human parathyroid hormone (1-34) on trabecular connectivity in ovariectomized rats
    Tsuchida, T
    Miyakoshi, N
    Kudo, T
    Tamura, Y
    Kasukawa, Y
    Suzuki, K
    Sato, K
    TOHOKU JOURNAL OF EXPERIMENTAL MEDICINE, 2001, 194 (04): : 213 - 221
  • [39] Recombinant human parathyroid hormone 1-34: Pharmacokinetics, tissue distribution and excretion in rats
    Hu, Zeping
    Niu, Huisheng
    Yang, Xiaoxia
    Li, Huaifen
    Sang, Guowei
    Li, Bo
    INTERNATIONAL JOURNAL OF PHARMACEUTICS, 2006, 317 (02) : 144 - 154
  • [40] Human parathyroid hormone (1-34) increases urinary excretion of lysosomal enzymes in rats
    Iwata, T
    Uchida, S
    Hori, M
    Sakai, K
    Towatari, T
    Kido, H
    LIFE SCIENCES, 1999, 65 (17) : 1725 - 1732